Alimentary Health Receives Orphan-drug Designation for the Treatment of Pediatric Ulcerative Colitis
Cork, Ireland, 13 May, 2008
Alimentary Health Ltd. (Alimentary Health),today announces that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA), has granted orphan-drug designation to Bifidobacterium infantis 35624 for the treatment of pediatric ulcerative colitis (UC).